Cargando…
Outcome and preferences in female-to-male subjects with gender dysphoria: Experience from Eastern India
CONTEXT: Awareness of gender dysphoria (GD) and its treatment is increasing. There is paucity of scientific data from India regarding the therapeutic options being used for alleviating GD, which includes psychotherapy, hormone, and surgical treatments. AIM: To study the therapeutic options including...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855956/ https://www.ncbi.nlm.nih.gov/pubmed/27186545 http://dx.doi.org/10.4103/2230-8210.179988 |
_version_ | 1782430439084916736 |
---|---|
author | Majumder, Anirban Sanyal, Debmalya |
author_facet | Majumder, Anirban Sanyal, Debmalya |
author_sort | Majumder, Anirban |
collection | PubMed |
description | CONTEXT: Awareness of gender dysphoria (GD) and its treatment is increasing. There is paucity of scientific data from India regarding the therapeutic options being used for alleviating GD, which includes psychotherapy, hormone, and surgical treatments. AIM: To study the therapeutic options including psychotherapy, hormone, and surgical treatments used for alleviating GD. SETTINGS AND DESIGN: This is a retrospective study of treatment preferences and outcome in 18 female-to-male (FTM) transgender subjects who presented to the endocrine clinic. RESULTS: The mean follow-up was 1.6 years and only one subject was lost to follow-up after a single visit. All subjects desiring treatment had regular counseling and medical monitoring. All FTM subjects were cross-dressing. Seventeen (94.4%) FTM subjects were receiving cross-sex hormone therapy, in the form of testosterone only (61.1%) or gonadotropin-releasing hormone (GnRH) agonist in combination with testosterone (11.1%) or medroxyprogesterone acetate (MPA) depot in combination with testosterone (22.2%). FTM subjects preferred testosterone or testosterone plus MPA; very few could afford GnRH therapy. Testosterone esters injection was preferred by most (72.2%) subjects as it was most affordable while 22.2% chose 3 monthly injections of testosterone undecanoate for convenience and better symptomatic improvement, but it was more expensive. None preferred testosterone gels because of cost and availability concerns. About 33.3% of our subjects underwent mastectomy, 38.9% had hysterectomy with bilateral salpingo-oophorectomy, and only one subject underwent phalloplasty. About 16.7% of FTM subjects presented with prior mastectomy depicting a high prevalence of unsupervised or poorly supervised surgeries not following protocol wise approach. CONCLUSION: Notwithstanding of advances in Standards of Care in the Western world, there is lack of awareness and acceptance in the FTM subjects, about proper and timely protocol-wise management options leading to suboptimal physical, social, and sexual results. |
format | Online Article Text |
id | pubmed-4855956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-48559562016-05-16 Outcome and preferences in female-to-male subjects with gender dysphoria: Experience from Eastern India Majumder, Anirban Sanyal, Debmalya Indian J Endocrinol Metab Original Article CONTEXT: Awareness of gender dysphoria (GD) and its treatment is increasing. There is paucity of scientific data from India regarding the therapeutic options being used for alleviating GD, which includes psychotherapy, hormone, and surgical treatments. AIM: To study the therapeutic options including psychotherapy, hormone, and surgical treatments used for alleviating GD. SETTINGS AND DESIGN: This is a retrospective study of treatment preferences and outcome in 18 female-to-male (FTM) transgender subjects who presented to the endocrine clinic. RESULTS: The mean follow-up was 1.6 years and only one subject was lost to follow-up after a single visit. All subjects desiring treatment had regular counseling and medical monitoring. All FTM subjects were cross-dressing. Seventeen (94.4%) FTM subjects were receiving cross-sex hormone therapy, in the form of testosterone only (61.1%) or gonadotropin-releasing hormone (GnRH) agonist in combination with testosterone (11.1%) or medroxyprogesterone acetate (MPA) depot in combination with testosterone (22.2%). FTM subjects preferred testosterone or testosterone plus MPA; very few could afford GnRH therapy. Testosterone esters injection was preferred by most (72.2%) subjects as it was most affordable while 22.2% chose 3 monthly injections of testosterone undecanoate for convenience and better symptomatic improvement, but it was more expensive. None preferred testosterone gels because of cost and availability concerns. About 33.3% of our subjects underwent mastectomy, 38.9% had hysterectomy with bilateral salpingo-oophorectomy, and only one subject underwent phalloplasty. About 16.7% of FTM subjects presented with prior mastectomy depicting a high prevalence of unsupervised or poorly supervised surgeries not following protocol wise approach. CONCLUSION: Notwithstanding of advances in Standards of Care in the Western world, there is lack of awareness and acceptance in the FTM subjects, about proper and timely protocol-wise management options leading to suboptimal physical, social, and sexual results. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4855956/ /pubmed/27186545 http://dx.doi.org/10.4103/2230-8210.179988 Text en Copyright: © 2016 Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Majumder, Anirban Sanyal, Debmalya Outcome and preferences in female-to-male subjects with gender dysphoria: Experience from Eastern India |
title | Outcome and preferences in female-to-male subjects with gender dysphoria: Experience from Eastern India |
title_full | Outcome and preferences in female-to-male subjects with gender dysphoria: Experience from Eastern India |
title_fullStr | Outcome and preferences in female-to-male subjects with gender dysphoria: Experience from Eastern India |
title_full_unstemmed | Outcome and preferences in female-to-male subjects with gender dysphoria: Experience from Eastern India |
title_short | Outcome and preferences in female-to-male subjects with gender dysphoria: Experience from Eastern India |
title_sort | outcome and preferences in female-to-male subjects with gender dysphoria: experience from eastern india |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855956/ https://www.ncbi.nlm.nih.gov/pubmed/27186545 http://dx.doi.org/10.4103/2230-8210.179988 |
work_keys_str_mv | AT majumderanirban outcomeandpreferencesinfemaletomalesubjectswithgenderdysphoriaexperiencefromeasternindia AT sanyaldebmalya outcomeandpreferencesinfemaletomalesubjectswithgenderdysphoriaexperiencefromeasternindia |